Actualité - Découvrez les nouveautés !
Vous trouvez ici les dernières nouveautés concernant les événements, les développements de produits et les publications de l'entreprise.
Grow your practice through anterior segment specialization
How can optometrists stand out in a crowded market? In this powerful Optometry Times editorial, Dr. Randy Charrier shares how specializing in anterior segment care helped him distinguish his practice and develop a loyal patient base.
En savoir plus
Taking Your OCT Outside of the Posterior Pole
Optical coherence tomography (OCT) has been the standard-of-care, "must-have " since its introduction over 20 years ago.
En savoir plus
Orbis 2024 Donor Impact Report
We are proud to support Orbis in advancing eye health services in underserved regions through their award-winning telemedicine platform, Cybersight.
En savoir plus
The vitreous—remember me?
The article by Jim Williamson, OD, explores the anatomy and function of this lesser-known body and how SPECTRALIS OCT helps monitor for disease or injury.
En savoir plus
Eyewire TV Episode 10.23.2024: Heidelberg SPECTRALIS Flex Module
In this video interview from the 2024 AAO meeting, principal investigator Lejla Vajzovic, MD, explains how the recently FDA-cleared SPECTRALIS Flex Module allows eyecare providers to image patients in a supine position.
En savoir plus
ASRS 2024: Real-world safety and efficacy of aflibercept 8 mg in the treatment nAMD
Listen to Deepak Sambhara, MD, present the findings from a real-world case study that measured the safety and efficacy of Aflibercept 8 mg for treating nonexudative AMD at ASRS 2024.
En savoir plus
Podcast, Part 2: What is Geographic Atrophy? Making the Invisible, Visible
Host Chris Lievens, OD chats with retinal experts, Jessica Haynes, OD and Steven Ferrucci, OD about the importance of high-quality imaging.
En savoir plus
Podcast, Part 1: What is Geographic Atrophy? Making the Invisible, Visible
Host Chris Lievens, OD sits down with retinal experts, Jessica Haynes, OD and Steven Ferrucci, OD to discuss geographic atrophy. They cover its prevalence and development, the role of high-quality imaging (SPECTRALIS, Heidelberg), and the importance of the doctor-patient relationship.
En savoir plus
The importance of multimodal imaging in the diagnosis of AMD and geographic atrophy
The U.S. Food and Drug Administration (FDA) has approved a drug for the treatment of geographic atrophy (GA) for the first time, one of the advanced forms of dry age-related macular degeneration (AMD). The approval is considered a breakthrough in ophthalmology and finally gives patients hope of positively impacting the course of the disease.
En savoir plus
Heidelberg Engineering startet mit neuem Vertriebspartner in der Türkei
Seit dem 1. Januar 2023 übernimmt unser neuer offizieller Partner, OCULAMED Medikal Elektronik Ltd. Sti., die Distribution unseres wachsenden Produktportfolios in der Türkei und wird weiterhin den hohen Standard an Service und Weiterbildung anbieten, den Heidelberg Engineering Kund:innen gewohnt sind.
En savoir plus